MedDx Solutions Limited - Accounts to registrar (filleted) - small 18.2

MedDx Solutions Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.2.0.360 08688185 Board of Directors 1.1.17 31.12.17 31.12.17 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure086881852016-12-31086881852017-12-31086881852017-01-012017-12-31086881852015-12-31086881852016-01-012016-12-31086881852016-12-3108688185ns15:EnglandWales2017-01-012017-12-3108688185ns14:PoundSterling2017-01-012017-12-3108688185ns10:Director12017-01-012017-12-3108688185ns10:PrivateLimitedCompanyLtd2017-01-012017-12-3108688185ns10:SmallEntities2017-01-012017-12-3108688185ns10:AuditExempt-NoAccountantsReport2017-01-012017-12-3108688185ns10:SmallCompaniesRegimeForDirectorsReport2017-01-012017-12-3108688185ns10:SmallCompaniesRegimeForAccounts2017-01-012017-12-3108688185ns10:AbridgedAccounts2017-01-012017-12-310868818512017-01-012017-12-3108688185ns10:Director22017-01-012017-12-3108688185ns10:Director32017-01-012017-12-3108688185ns10:RegisteredOffice2017-01-012017-12-3108688185ns5:CurrentFinancialInstruments2017-12-3108688185ns5:CurrentFinancialInstruments2016-12-3108688185ns5:Non-currentFinancialInstruments2017-12-3108688185ns5:Non-currentFinancialInstruments2016-12-3108688185ns5:ShareCapital2017-12-3108688185ns5:ShareCapital2016-12-3108688185ns5:RetainedEarningsAccumulatedLosses2017-12-3108688185ns5:RetainedEarningsAccumulatedLosses2016-12-3108688185ns5:PatentsTrademarksLicencesConcessionsSimilar2017-01-012017-12-3108688185ns5:PlantMachinery2017-01-012017-12-3108688185ns5:FurnitureFittings2017-01-012017-12-3108688185ns5:CurrentFinancialInstrumentsns5:HirePurchaseContractsns5:WithinOneYear2017-12-3108688185ns5:CurrentFinancialInstrumentsns5:HirePurchaseContractsns5:WithinOneYear2016-12-3108688185ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2017-12-3108688185ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2016-12-3108688185ns5:HirePurchaseContracts2017-12-3108688185ns5:HirePurchaseContracts2016-12-3108688185ns5:WithinOneYear2017-12-3108688185ns5:WithinOneYear2016-12-3108688185ns5:BetweenOneFiveYears2017-12-3108688185ns5:BetweenOneFiveYears2016-12-3108688185ns5:MoreThanFiveYears2017-12-3108688185ns5:MoreThanFiveYears2016-12-3108688185ns5:AllPeriods2017-12-3108688185ns5:AllPeriods2016-12-31


REGISTERED NUMBER: 08688185 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2017

for

MedDx Solutions Limited

MedDx Solutions Limited (Registered number: 08688185)

Contents of the Financial Statements
for the year ended 31 December 2017










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


MedDx Solutions Limited

Company Information
for the year ended 31 December 2017







Directors: R J Senior
R I Davidson
E A Madden





Registered office: Unit 3, Skylon Place
Hursey Road
Rotherwas
Hereford
HR2 6NX





Registered number: 08688185 (England and Wales)





Accountants: Acre Accountancy Limited
Unit 2 Foley Works
Foley Industrial Estate
Hereford
Herefordshire
HR1 2SF

MedDx Solutions Limited (Registered number: 08688185)

Abridged Balance Sheet
31 December 2017

2017 2016
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 86,975 95,673
Tangible assets 5 163,282 101,309
250,257 196,982

CURRENT ASSETS
Stocks 159,286 168,444
Debtors 251,246 185,833
Cash at bank and in hand 58,521 93,173
469,053 447,450
CREDITORS
Amounts falling due within one year 242,085 244,047
NET CURRENT ASSETS 226,968 203,403
TOTAL ASSETS LESS CURRENT
LIABILITIES

477,225

400,385

CREDITORS
Amounts falling due after more than one
year

(393,125

)

(356,376

)

PROVISIONS FOR LIABILITIES (24,667 ) (12,351 )
NET ASSETS 59,433 31,658

CAPITAL AND RESERVES
Called up share capital 300 300
Retained earnings 59,133 31,358
SHAREHOLDERS' FUNDS 59,433 31,658

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

MedDx Solutions Limited (Registered number: 08688185)

Abridged Balance Sheet - continued
31 December 2017


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 December 2017 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors on 24 September 2018 and were signed on its behalf
by:





R J Senior - Director


MedDx Solutions Limited (Registered number: 08688185)

Notes to the Financial Statements
for the year ended 31 December 2017


1. STATUTORY INFORMATION

MedDx Solutions Limited is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

No adjustments were made to the reported financial position and performance of the company on its first-time
adoption of FRS102 (Section 1A).

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for sales of good and services
in the ordinary course of the business. Turnover is shown net of Value Added Tax, for goods and services
provided to customers.

Intangible assets - patents
Costs incurred in acquiring or developing patent rights are capitalised where the directors consider that the
company will benefit from the use of the patent rights. At each accounting period the directors consider whether
there has been any impairment in the value of such patent rights. Where the directors consider that the value of
patent rights reduces over time, the directors amortise the value on a straight line basis over the useful economic
life of the asset. In 2016 the company commenced the amortisation of patent costs over the useful economic life
of 12 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - at varying rates on cost
Fixtures and fittings - 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except
to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.


MedDx Solutions Limited (Registered number: 08688185)

Notes to the Financial Statements - continued
for the year ended 31 December 2017


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the
lease.

Assets obtained under hire purchase and finance leases are capitalised as tangible assets and depreciated over
their useful lives in accordance with depreciation policy. Obligations under such agreements are included in
creditors net of the finance charge allocated to future periods. The finance element of the lease payments is
charged to the profit and loss account over the period of the contract.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for according to the substance of the contractual arrangement.
They are classified as financial assets, financial liabilities or equity instruments. An equity instrument is any
contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Government grants
Government grants, where revenue in nature, are recognised as income in the profit and loss account in the same
period in which the related expenditure is recognised.

Grants related to assets are initially credited to a deferral account in creditors and are released to the profit and
loss account as the related asset is depreciated.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2016 - 11 ) .

4. INTANGIBLE FIXED ASSETS

Other intangible assets relates to the value of patent rights held by the company.

MedDx Solutions Limited (Registered number: 08688185)

Notes to the Financial Statements - continued
for the year ended 31 December 2017


5. TANGIBLE FIXED ASSETS
Totals
£   
Cost
At 1 January 2017 204,565
Additions 95,237
At 31 December 2017 299,802
Depreciation
At 1 January 2017 103,256
Charge for year 33,264
At 31 December 2017 136,520
Net book value
At 31 December 2017 163,282
At 31 December 2016 101,309

6. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
2017 2016
£    £   
Net obligations repayable:
Within one year 17,500 13,701
Between one and five years 48,125 11,376
65,625 25,077

Non-cancellable operating
leases
2017 2016
£    £   
Within one year 55,345 51,800
Between one and five years 175,495 188,300
In more than five years 141,800 184,340
372,640 424,440

7. SECURED DEBTS

The following secured debts are included within creditors:

2017 2016
£    £   
Hire purchase contracts 65,625 25,077

Hire purchase debts are secured on certain fixed assets of the company.

MedDx Solutions Limited (Registered number: 08688185)

Notes to the Financial Statements - continued
for the year ended 31 December 2017


8. RELATED PARTY DISCLOSURES

The company was under the control of its directors, by virtue of their shareholdings (held directly or by other
related parties).